Awareness, Willingness, and Perceived Efficacy of Pre-exposure Prophylaxis among Adolescent Sexual Minority Males.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Kuhns, Lisa M
Batey, D Scott
Hidalgo, Marco A
Schrimshaw, Eric W
Human immunodeficiency virus (HIV)
Pre-exposure prophylaxis (PrEP)
Journal titleJournal of urban health : bulletin of the New York Academy of Medicine
Publication Begin page749
Publication End page757
MetadataShow full item record
AbstractDespite the approval of PrEP for adolescents by the FDA in 2018, little is known about the awareness and attitudes about PrEP use among adolescent sexual minority males, who are at the greatest risk for HIV. We analyzed baseline data from the MyPEEPS Mobile study, a multi-site randomized controlled trial evaluating the effectiveness of a mobile behavioral HIV prevention intervention. A substantial proportion (68.2%) of study participants (ages 13-18) had previously heard about PrEP, and an overwhelming majority (90.8%) reported willingness to take PrEP, to prevent HIV. On the other hand, only about one third (34.6%) of participants indicated that taking a daily HIV pill would be "very" or "completely" effective in preventing HIV when having sex without a condom. These findings suggest that high awareness and willingness to use PrEP across various adolescent subgroups present opportunities for increased PrEP advocacy among this young age group.
CitationGordián-Arroyo A, Garofalo R, Kuhns LM, Pearson C, Bruce J, Batey DS, Radix A, Belkind U, Hidalgo MA, Hirshfield S, Schrimshaw EW, Schnall R. Awareness, Willingness, and Perceived Efficacy of Pre-exposure Prophylaxis among Adolescent Sexual Minority Males. J Urban Health. 2020 Oct;97(5):749-757. doi: 10.1007/s11524-020-00447-5. PMID: 32789625; PMCID: PMC7560632.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
- Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States, 2021-2022: cross-sectional study.
- Authors: Schoenberg P, Edwards OW, Merrill L, Martinez CA, Stephenson R, Sullivan PS, Jones J
- Issue date: 2023 Mar
- "I prefer to take pills when I plan to have sex": Perceptions of on-demand versus daily oral pre-exposure prophylaxis among adolescents in Kampala, Uganda.
- Authors: Kawuma R, Nabalwanyi Z, Seeley J, Mayanja Y
- Issue date: 2022 Mar